ANAB

ANAB

ANAB

Market Cap: $1.53B

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2026 Q2 Aug 13, 2026 Greenhaven Road Capital 11.0% - ANAB, APP, CODI, GSK, KKR, LFCR, LQDA, PAR, PPC, TSN AI, Biotechnology, catalysts, insurance, Litigation Finance, small caps, special situations, value
2026 Q2 Jul 24, 2026 Summers Value Fund 41.7% 37.8% ANAB, CCSI, ELMD, EMBC, HALO, LGND, LQDA Biotechnology, healthcare, M&A, royalties, small caps, special situations, value CCSI
2026 Q2 Jul 14, 2026 Laughing Water Capital 39.8% 33.6% ANAB, AVNS, GFL, GSK, LFCR, LQDA, LRN, NN, SES.TO, TBPH, UTHR Biopharma M&A, catalysts, healthcare, Litigation, royalties, small caps, special situations, value

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Jun 16, 2026 Substack Triples Investing AnaptysBio Biotechnology Pharmaceuticals Bull NASDAQ Stock Market AnaptysBio, biotechnology, cancer drug, GlaxoSmithKline lawsuit, investment opportunity, Jemperli, pharmaceuticals, psoriasis drug, Royalty Streams, Sagard loan
Apr 1, 2026 Substack Toff Cap Monday Monitor AnaptysBio Biotechnology Biopharmaceuticals Bull NASDAQ Stock Market biotechnology, clinical stage, GSK, Immuno-oncology, royalties, shareholder value, spin-off, strategic separation, valuation, Vanda
Oct 6, 2025 Substack Toff Cap Monday Monitor AnaptysBio Health Care Biotechnology Bull biotechnology, clinical stage, GSK, independent companies, royalty business, shareholder value, spin-off, valuation, Vanda
Aug 8, 2025 Seeking Alpha Bret Jensen AnaptysBio, Inc. Health Care Biotechnology Neutral NASDAQ

BSD Shareholders of ANAB

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
Oleg Nodelman EcoR1 Capital $2.2B $382.0M 17.33% 7,880,094 +0 +0.00% 24.9079%
Paul Tudor Jones Tudor Investment Corp $53.4B $838,946 0.00% 17,305 -10,433 -37.61% 0.0547%
Steven A. Cohen Point72 Asset Management $86.8B $93.7M 0.11% 1,932,890 -332,638 -14.68% 6.1096%
Cliff Asness AQR Capital Management $190.6B $1.3M 0.00% 26,309 +135 +0.52% 0.0832%
Israel Englander Millennium Management LLC $233.2B $39.4M 0.02% 813,571 -705,659 -46.45% 2.5716%
David Siegel & John Overdeck Two Sigma Investments $67.5B $12.4M 0.02% 256,635 +215 +0.08% 0.8112%
Jayson Yuan Palo Alto Investors LP $718.4M $33.5M 4.66% 690,032 +16,512 +2.45% 2.1811%